Ocular Therapeutix Inc OCUL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
6.27quote price arrow down-0.02 (-0.32%)
Volume
3,903,254
52 week range
2.00 - 11.31
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.27
  • 52 Week High11.31
  • 52 Week High Date03/06/24
  • 52 Week Low2.00
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap971.153M
  • Shares Out154.89M
  • 10 Day Average Volume3.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change40.58

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.27
  • 52 Week High11.31
  • 52 Week High Date03/06/24
  • 52 Week Low2.00
  • 52 Week Low Date11/10/23
  • Market Cap971.153M
  • Shares Out154.89M
  • 10 Day Average Volume3.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change40.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-5.73
  • Fwd P/E (NTM)-7.48
  • EBITDA (TTM)-88.031M
  • ROE (TTM)-55.19%
  • Revenue (TTM)59.842M
  • Gross Margin (TTM)90.99%
  • Net Margin (TTM)-192.62%
  • Debt To Equity (MRQ)16.29%

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocular Therapeutix Inc

 

Profile

MORE
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. It is also developing two other...
Pravin Dugel M.D.
Executive Chairman of the Board, President, Chief Executive Officer
Donald Notman Jr.
Chief Financial Officer
Peter Jarrett Ph.D.
Chief Technical Officer
Philip Strassburger Esq., J.D.
General Counsel
Address
15 Crosby Drive
Bedford, MA
01730
United States

Top Peers

SYMBOLLASTCHG%CHG
EYPT
EyePoint Pharmaceuticals Inc
12.52-0.42-3.25%
SIGA
SIGA Technologies Inc
7.90+0.10+1.28%
AVDL
Avadel Pharmaceuticals PLC
15.94-0.15-0.93%
AQST
Aquestive Therapeutics Inc
3.28+0.06+1.86%
HROW
Harrow Inc
16.16+0.23+1.48%